CONTINUE TO SITE
OR WAIT 15 SECS
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Almac Discovery, a
Japan headquartered Shionogi & Co. has entered into a comprehensive partnership agreement with Nagasaki Un
South Korea-based startup ABL Bio Inc. has announced a worldwide licensing agreement enabling GlaxoSmithK
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driv
As part of its commitment to advance healthcare innovation, the Department of Health – Abu Dhabi (DoH),
Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, recently held bilateral talks
South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therape
At the annual event of Indonesian Women Imaging Society held recently, Siemens Healthineers has unveiled the M
US-based AGC Biologics, a global Contract Development and Manufacturing Organisation (CDMO), has announced a m
South Korea-based Lotte Biologics has signed a manufacturing agreement with an Asia-based biotech co
APAC Vaccine Powerhouses Flex Capacity & Quality Muscle
Asia is the epicentre of global vaccine manufacturing, with India and China together supplying over a billion doses annually. Now, emerging players like South Korea, Singapore, and Australia are stepping up, investing in next-gen platforms and expanding capacity to meet global demand. Let’s map the manufacturing footprint of Asia’s leading vaccine manufacturers, tracking their current capacity, expansion plans, and the strategic shifts that are transforming the region into a global vaccine production hub.
ISPOR 2025
ISPOR
info@ispor.org https://www.ispor.org/conferences-education/event/2025/05/13/default-calendar/ispor-2025Montreal
Cell Gene Meeting on the Med 2025
"Alliance for Regenerative Medicine"
sbryant@alliancerm.org https://alliancerm.org/arm-event/meetingonthemed/Rome
